In Romania, Dr. Reddy’s Laboratories Ltd. began operations 19 years ago. Throughout its evolution, the representative of Romania increased at a rate of over 20 percent annually, one of the fastest in the international subsidiaries. Today, the team from Romania, has reached almost 100 people, runs a business of approx. USD 20 million, built on a portfolio of over 20 generic prescription drugs.
Address: Str. Nicholae Caramfil, No. 71-73, Et. 5, Sector 1, Bucharest
—
Within a broad assessment of Romania’s investment climate, there is no doubt that every country has some key factors upon which can be capitalized to attract foreign investors. In sum,…
You have become the head of Novo Nordisk’s operations in Romania in March 2008. Can you first give our readers an idea on how the market environment was at that…
You have been the first employee to start Dr. Reddy’s in Romania and when we look back at those early years, we see that a portfolio of gastroenterology and analgesics…
You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can you first elaborate on…
You have only just arrived from Korea to head the Romanian operations at MSD. Just recently, you told in an interview with Medica Academica that MSD Romania enjoys a good…
You have been the first employee to start Dr. Reddy’s in Romania and when we look back at those early years, we see that a portfolio of gastroenterology and analgesics…
Apart from MNCs, there are many local businesses that are rather strong in the Romanian pharmaceutical market. Could you give our readers an idea of their main strengths? There is…
While, today, you are in charge of voicing the concerns of the innovators in the country, let us first take a step back and see what attracted these companies to…
In order to provide our readers with a general idea of the current state of the Romanian pharmaceutical and healthcare sectors, can you first of all elaborate on the key…
Increasing integration with the world economy and accession to the European Union (EU) in 2007 have been key pillars in taking the growth potential of Romania’s pharmaceutical market to greater…
You have been general manager of this affiliate for three years after a previous tenure as general manager of Leo Pharma here and in Bulgaria. The end of 2008 through…
We understand that you have been heading IMS Health in Romania for 10 years now, which has been quite a trajectory. Therefore, can you highlight the key milestones and achievements…
See our Cookie Privacy Policy Here
